Disc Medicine (IRON) EBT (2020 - 2026)
Disc Medicine (IRON) reported EBT of -$63.5 million for Q1 2026, down 86.81% year-over-year from -$481.2 million in Q1 2025, and down 4.41% quarter-over-quarter from -$60.8 million in Q4 2025.
Disc Medicine (IRON) EBT (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of EBT data on file, last reported at -$63.5 million in Q1 2026.
- EBT for Q1 2026 came in at -$63.5 million, down 86.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$241.6 million (down 108.27% YoY), and the FY2025 annual result was -$212.2 million, down 94.63% from the prior year.
- EBT slipped to -$63.5 million in Q1 2026 per IRON's latest filing, from -$60.8 million in the prior quarter.
- Over five years, EBT peaked at -$9.6 million in Q2 2022 and troughed at -$63.5 million in Q1 2026.
- A 5-year average of -$29.9 million and a median of -$26.3 million in 2024 frame the typical range for EBT.
- On a YoY basis, EBT climbed as much as 46.27% in 2022 and fell as far as 161.83% in 2022.
- A 5-year view of EBT shows it stood at -$11.2 million in 2022, then tumbled by 109.42% to -$23.5 million in 2023, then fell by 24.35% to -$29.3 million in 2024, then plunged by 107.55% to -$60.8 million in 2025, then dropped by 4.41% to -$63.5 million in 2026.
- Business Quant data shows IRON's EBT at -$63.5 million in Q1 2026, -$60.8 million in Q4 2025, and -$62.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - | -63.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.45 Mn |
| Dec 31, 2025 | -60.77 Mn |
| Sep 30, 2025 | -62.22 Mn |
| Jun 30, 2025 | -55.20 Mn |
| Mar 31, 2025 | -33.97 Mn |
| Dec 31, 2024 | -29.28 Mn |
| Sep 30, 2024 | -26.49 Mn |
| Jun 30, 2024 | -26.29 Mn |
| Mar 31, 2024 | -26.94 Mn |
| Dec 31, 2023 | -23.55 Mn |
| Sep 30, 2023 | -14.10 Mn |
| Jun 30, 2023 | -15.92 Mn |
| Mar 31, 2023 | -22.76 Mn |
| Dec 31, 2022 | -11.24 Mn |
| Sep 30, 2022 | -16.15 Mn |
| Jun 30, 2022 | -9.58 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | 18.19 Mn |
| Sep 30, 2021 | -18.45 Mn |
| Jun 30, 2021 | -16.44 Mn |